Emma J Chapman1, Zoe Edwards1, Jason W Boland2, Matthew Maddocks3, Lucy Fettes3, Catherine Malia4, Matthew R Mulvey1, Michael I Bennett1. 1. Academic Unit of Palliative Care, Leeds Institute of Health Sciences, Leeds, UK. 2. Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK. 3. Cicely Saunders Institute of Palliative Care, Policy & Rehabilitation, Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, London, UK. 4. St Gemma's Hospice, Leeds, UK.
Abstract
BACKGROUND: Pain of a moderate or severe intensity affects over half of patients with advanced cancer and remains undertreated in at least one-third of these patients. AIM: The aim of this study was to provide a pragmatic overview of the evidence supporting the use of interventions in pain management in advanced cancer and to identify where encouraging preliminary results are demonstrated but further research is required. DESIGN: A scoping review approach was used to examine the evidence supporting the use of guideline-recommended interventions in pain management practice. DATA SOURCES: National or international guidelines were selected if they described pain management in adult cancer patients and were written within the last 5 years in English. The Cochrane Database of Systematic Reviews (January 2014 to January 2019) was searched for 'cancer' AND 'pain' in the title, abstract or keywords. A MEDLINE search was also made. RESULTS: A strong opioid remains the drug of choice for treating moderate or severe pain. Bisphosphonates and radiotherapy are also effective for cancer-related bone pain. Optimal management requires a tailored approach, support for self-management and review of treatment outcomes. There is likely a role for non-pharmacological approaches. Paracetamol should not be used in patients taking a strong opioid to treat pain. Cannabis-based medicines are not recommended. Weak opioids, ketamine and lidocaine are indicated in specific situations only. CONCLUSION: Interventions commonly recommended by guidelines are not always supported by a robust evidence base. Research is required to evaluate the efficacy of non-steroidal anti-inflammatory drugs, anti-convulsants, anti-depressants, corticosteroids, some invasive anaesthetic techniques, complementary therapies and transcutaneous electrical nerve stimulation.
BACKGROUND:Pain of a moderate or severe intensity affects over half of patients with advanced cancer and remains undertreated in at least one-third of these patients. AIM: The aim of this study was to provide a pragmatic overview of the evidence supporting the use of interventions in pain management in advanced cancer and to identify where encouraging preliminary results are demonstrated but further research is required. DESIGN: A scoping review approach was used to examine the evidence supporting the use of guideline-recommended interventions in pain management practice. DATA SOURCES: National or international guidelines were selected if they described pain management in adult cancerpatients and were written within the last 5 years in English. The Cochrane Database of Systematic Reviews (January 2014 to January 2019) was searched for 'cancer' AND 'pain' in the title, abstract or keywords. A MEDLINE search was also made. RESULTS: A strong opioid remains the drug of choice for treating moderate or severe pain. Bisphosphonates and radiotherapy are also effective for cancer-related bone pain. Optimal management requires a tailored approach, support for self-management and review of treatment outcomes. There is likely a role for non-pharmacological approaches. Paracetamol should not be used in patients taking a strong opioid to treat pain. Cannabis-based medicines are not recommended. Weak opioids, ketamine and lidocaine are indicated in specific situations only. CONCLUSION: Interventions commonly recommended by guidelines are not always supported by a robust evidence base. Research is required to evaluate the efficacy of non-steroidal anti-inflammatory drugs, anti-convulsants, anti-depressants, corticosteroids, some invasive anaesthetic techniques, complementary therapies and transcutaneous electrical nerve stimulation.
Entities:
Keywords:
Pain; analgesia; evidence-based practice; neoplasms; review; terminal care
Authors: Piotr Pęczek; Monika Gajda; Kacper Rutkowski; Marta Fudalej; Andrzej Deptała; Anna M Badowska-Kozakiewicz Journal: J Cancer Res Clin Oncol Date: 2022-10-19 Impact factor: 4.322
Authors: Melanie R Lovell; Jane L Phillips; Tim Luckett; Lawrence Lam; Frances M Boyle; Patricia M Davidson; Seong L Cheah; Nicola McCaffrey; David C Currow; Tim Shaw; Annmarie Hosie; Bogda Koczwara; Stephen Clarke; Jessica Lee; Martin R Stockler; Caitlin Sheehan; Odette Spruijt; Katherine Allsopp; Alexandra Clinch; Katherine Clark; Alison Read; Meera Agar Journal: JAMA Netw Open Date: 2022-02-01
Authors: Elena Bandieri; Leonardo Potenza; Fabio Efficace; Eduardo Bruera; Mario Luppi Journal: Int J Environ Res Public Health Date: 2020-09-28 Impact factor: 3.390
Authors: Sarah L Alderson; Tracey M Farragher; Thomas A Willis; Paul Carder; Stella Johnson; Robbie Foy Journal: PLoS Med Date: 2021-10-04 Impact factor: 11.069
Authors: Billy Vinette; José Côté; Ali El-Akhras; Hazar Mrad; Gabrielle Chicoine; Karine Bilodeau Journal: BMC Cancer Date: 2022-03-24 Impact factor: 4.430